You are here: Industry Insights > Cancer

News List

Astellas, Adaptimmune sign deal to co-develop T-cell therapies for cancer pharmaceutical-business-review
January 17, 2020
Astellas Pharma has signed a deal worth up to $897.5m with Adaptimmune Therapeutics to co-develop and co-commercialise stem-cell derived allogeneic CAR-T and TCR T-cell therapies for cancer.
NICE requests more data on Keytruda for head and neck cancer treatment europeanpharmaceuticalreview
January 17, 2020
NICE has asked for more information on Keytruda (pembrolizumab) for untreated metastatic or unresectable recurrent squamous cell head and neck cancer due to uncertainty over clinical trial evidence.
Weight Control Drug Lorcaserin May Raise Cancer Risk drugs
January 16, 2020
The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the risk for cancer, according to the results of a clinical trial assessing the safety of the drug, the U.S. Food and Drug Administration says.
FDA issues alert for cancer risk from Belviq (lorcaserin) europeanpharmaceuticalreview
January 16, 2020
The US FDA has announced a warning to healthcare professionals and patients that the weight management drug Belviq may be a cause of cancer.
More Than Half of Cancer Survivors Don't Abstain From Alcohol drugs
January 15, 2020
U.S. cancer survivors have surprisingly high rates of alcohol use, researchers say. This study highlights the prevalence of current alcohol use among cancer survivors, including an increase in alcohol intake over time and higher rates among younger cancer
Plant-derived SVC112 hits cancer stem cells, leaves healthy cells alone worldpharmanews
January 14, 2020
The red, tube-shaped flowers of the firecracker bush (Bouvardia ternifolia), native to Mexico and the American Southwest, attract hummingbirds.
WPD New Discovery for Cancer Targeting Drugs Granted Patent americanpharmaceuticalreview
January 14, 2020
WPD Pharmaceuticals announced Wake Forest University received a patent from the United States Patent and Trademark Office (USPTO) for patent 105019210 (issued under application number 16/262,195v) licensed to WPD.
Pfizer signs oncology agreement with STR-focused eFFECTOR pharmaceutical-technology
January 14, 2020
San Diego-based eFFECTOR has signed an exclusive worldwide license and collaboration agreement with Pfizer in the oncology field. The collaboration focuses on the development of small molecule inhibitors of eukaryotic initiation factor 4E (elF4E) ...
Tyme and Eagle Pharmaceuticals partner for cancer candidate oral pharmaceutical-technology
January 09, 2020
Tyme Technologies has entered a strategic collaboration with Eagle Pharmaceuticals for cancer metabolism-based therapy (CMBT) candidate oral SM-88.
Statins May Do Double Duty on Heart Disease and Cancer drugs
January 07, 2020
About 40 million adults in the U.S. take a statin to lower their cholesterol and reduce the risk for heart disease. They might also be getting an added anti-cancer benefit, a growing body of evidence suggests.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page